Product Information
ZOLMITRIPTAN 2.5 MG ODT is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $2.0682 per EA under NDC 68462049976. Its NADAC has been published 650 times since Nov 28, 2013.
FDA first approved this application on May 14, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462049976
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ZOLMITRIPTANApproval Type
Generic (ANDA)
FDA Application
ANDA202560FDA Approved
5/14/2013
TE Code
AB
On Market Since
5/14/2013
Pharmacological Classes
Price Statistics
The NADAC for ZOLMITRIPTAN 2.5 MG ODT has been published 650 times since Nov 28, 2013, and over the history we have for it it has declined 73.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0682 per EA |
|---|---|
| All-time high | $8.5677 (Aug 12, 2015) |
| All-time low | $2.0682 (Sep 23, 2026) |
| 52-week high | $2.4682 |
| 52-week low | $2.0682 |
| Median price | $3.8381 |
| Average price | $4.7302 |
| Largest weekly change | +88.4% (Jul 20, 2022) |
| Weeks tracked | 650 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the zolmitriptan market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
zolmitriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZOLMITRIPTAN 2.5 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 2.5 MG ODT, manufactured by Glenmark Pharmaceuticals Inc., USA, is $2.0682 per EA (NDC 68462049976), effective Sep 30, 2026.
How has the price of ZOLMITRIPTAN 2.5 MG ODT changed over time?
Over the history we have for it, the NADAC for ZOLMITRIPTAN 2.5 MG ODT has declined 73.3%. It has been tracked across 650 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 2.5 MG ODT?
Since Nov 28, 2013, the NADAC for ZOLMITRIPTAN 2.5 MG ODT has ranged from a low of $2.0682 (Sep 23, 2026) to a high of $8.5677 (Aug 12, 2015), with a median of $3.8381 per EA.
Are there cheaper alternatives to ZOLMITRIPTAN 2.5 MG ODT?
No other NADAC-published product currently shares the active ingredient and strength of ZOLMITRIPTAN 2.5 MG ODT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZOLMITRIPTAN 2.5 MG ODT?
ZOLMITRIPTAN 2.5 MG ODT (NDC 68462049976) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.